Memorial Sloan Kettering nuclear medicine physician Ali Aria Razmaria

Ali Aria Razmaria, MD, MSc

Nuclear Medicine Physician

Clinical Expertise

Nuclear Medicine; PET/CT; Novel PET Tracers; Radionuclide Therapies

Back to Top
Share

Contact and Location

Locations map
Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.

See all locations

About Me

Education

MD, Univeristy of Vienna

Residencies

Nuclear Medicine - UCLA Medical Center

Fellowships

Oncologic Imaging - UCLA Medical Center

Board Certifications

Nuclear Medicine

As a nuclear medicine physician, my specialization is in the medical use of radioisotopes linked to distinct elements and molecules to characterize and treat disease processes in the body, such as cancer. Molecular imaging and therapy is changing the way we think about the detection and treatment of diseases, which is especially beneficial for people with cancer.

My research work is centered around genitourinary diseases and cancers with an emphasis on the diagnosis, imaging, and treatment of prostate cancer in its various stages. Equipped with clinical experience from training in family medicine, urology, and nuclear medicine, my research aims to answer clinical questions that directly translate to improved patient care.

The importance of patient-centered care in cancer treatment is evident to me based on personal experience of losing a family member to an aggressive type of prostate cancer. Since then, the guiding principle for me in practicing medicine has been to put myself in the shoes of patients to fully understand their situation and tailor recommendations accordingly.

Awards and Honors

  • Roentgen Fellow Research Award, Radiological Society of North America
  • Robert Henkin Award, Society of Nuclear Medicine and Molecular Imaging

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all Molecular Imaging and Therapy Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Razmaria’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Ali Aria Razmaria discloses the following relationships and financial interests:

No disclosures meeting criteria for time period


If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures